Pleural diseases encompass a wide range of conditions affecting the pleura, the thin membrane surrounding the lungs and lining the chest cavity. These conditions include pleural effusion, pneumothorax, pleuritis, empyema, and pleural tumors. Patients may present with chest discomfort, shortness of breath, cough, or asymptomatic findings detected incidentally on imaging. Accurate pleural disease diagnosis is essential to identify the underlying cause, guide treatment, and prevent complications such as lung collapse, infection, or fibrosis. Clinical assessment begins with a thorough history and physical examination, evaluating risk factors such as recent infections, trauma, malignancy, or systemic illnesses. Imaging modalities, including chest X-rays, ultrasound, and high-resolution CT scans, provide critical information on fluid accumulation, pleural thickening, or air collections.
Definitive diagnosis often requires targeted sampling of pleural fluid or tissue. Thoracentesis allows analysis of pleural fluid for cell count, chemistry, microbiology, and cytology, helping differentiate between transudative and exudative processes. In some cases, pleural biopsy or video-assisted thoracoscopic surgery may be needed to detect malignancy or chronic inflammatory conditions. Ongoing monitoring through imaging and laboratory studies is crucial to track disease progression and assess response to therapy. Multidisciplinary involvement—including pulmonologists, radiologists, and thoracic surgeons—ensures comprehensive evaluation, individualized treatment planning, and timely intervention. By combining careful clinical assessment, advanced imaging, and procedural diagnostics, pleural disease diagnosis can accurately identify underlying causes, optimize patient outcomes, and reduce long-term respiratory complications.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation